CA2949754A1 - Use of aminoglycoside analogs in the treatment of rett syndrome - Google Patents

Use of aminoglycoside analogs in the treatment of rett syndrome Download PDF

Info

Publication number
CA2949754A1
CA2949754A1 CA2949754A CA2949754A CA2949754A1 CA 2949754 A1 CA2949754 A1 CA 2949754A1 CA 2949754 A CA2949754 A CA 2949754A CA 2949754 A CA2949754 A CA 2949754A CA 2949754 A1 CA2949754 A1 CA 2949754A1
Authority
CA
Canada
Prior art keywords
compound
alkyl
mecp2
rett syndrome
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2949754A
Other languages
English (en)
French (fr)
Inventor
Timor Baasov
Shmuel Tuvia
Dori Pelled
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eloxx Pharmaceuticals Ltd
Original Assignee
Eloxx Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eloxx Pharmaceuticals Ltd filed Critical Eloxx Pharmaceuticals Ltd
Publication of CA2949754A1 publication Critical patent/CA2949754A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA2949754A 2014-06-05 2015-06-04 Use of aminoglycoside analogs in the treatment of rett syndrome Abandoned CA2949754A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462008028P 2014-06-05 2014-06-05
US62/008,028 2014-06-05
PCT/IL2015/050573 WO2015186134A1 (en) 2014-06-05 2015-06-04 Use of aminoglycoside analogs in the treatment of rett syndrome

Publications (1)

Publication Number Publication Date
CA2949754A1 true CA2949754A1 (en) 2015-12-10

Family

ID=53525222

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2949754A Abandoned CA2949754A1 (en) 2014-06-05 2015-06-04 Use of aminoglycoside analogs in the treatment of rett syndrome

Country Status (6)

Country Link
US (2) US20170360817A1 (enExample)
EP (1) EP3151840A1 (enExample)
JP (1) JP2017516835A (enExample)
CA (1) CA2949754A1 (enExample)
IL (1) IL249402A0 (enExample)
WO (1) WO2015186134A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT201800019T1 (it) 2010-11-18 2018-03-08 Technion Res & Dev Foundation Amminoglicosidi e relativi usi nel trattamento di malattie genetiche
US20170360817A1 (en) 2014-06-05 2017-12-21 Eloxx Pharmaceuticals Ltd. Use of aminoglycoside analogs in the treatment of rett syndrome
EP3350194A4 (en) 2015-09-02 2019-04-24 Eloxx Pharmaceuticals Ltd. AMINO-LIKES DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF GENETIC DISEASES
CA2996763A1 (en) * 2015-09-02 2017-03-09 Eloxx Pharmaceuticals Ltd. Aminoglycoside derivatives and uses thereof in treating genetic disorders
WO2017037717A1 (en) 2015-09-02 2017-03-09 Eloxx Pharmaceuticals Ltd. Aminoglycoside derivatives and uses thereof in treating genetic disorders
EP3609902A4 (en) * 2017-03-15 2021-01-06 Eloxx Pharmaceuticals Ltd. LARGE-SCALE PREPARATION OF PSEUDO-TRISACCHARIDE AMINOGLYCOSIDES AND INTERMEDIARIES THEREOF

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5960712A (ja) 1982-09-30 1984-04-06 Toshiba Corp デ−タ判別装置
CA2554380C (en) * 2004-02-17 2015-05-19 The Hospital For Sick Children Mecp2e1 gene
HUE031643T2 (en) 2006-04-03 2017-07-28 Technion Res & Dev Foundation New aminoglycosides and their applications in the treatment of genetic disorders
SMT201800019T1 (it) * 2010-11-18 2018-03-08 Technion Res & Dev Foundation Amminoglicosidi e relativi usi nel trattamento di malattie genetiche
US20170360817A1 (en) 2014-06-05 2017-12-21 Eloxx Pharmaceuticals Ltd. Use of aminoglycoside analogs in the treatment of rett syndrome

Also Published As

Publication number Publication date
US20170360817A1 (en) 2017-12-21
US20190183915A1 (en) 2019-06-20
EP3151840A1 (en) 2017-04-12
US10576095B2 (en) 2020-03-03
IL249402A0 (en) 2017-02-28
WO2015186134A1 (en) 2015-12-10
JP2017516835A (ja) 2017-06-22

Similar Documents

Publication Publication Date Title
US10576095B2 (en) Use of aminoglycoside analogs in the treatment of Rett syndrome
RU2677276C2 (ru) Способы лечения рака
US20210292316A1 (en) Compounds for the treatment of cancer
Dileep et al. Synthesis of novel tetrazole containing hybrid ciprofloxacin and pipemidic acid analogues and preliminary biological evaluation of their antibacterial and antiproliferative activity
US12285470B2 (en) Trim proteins and galectins cooperate and codirect autophagy and are useful in the treatment of autophagy related diseases
US11786539B2 (en) Aminoglycoside derivatives and uses thereof in treating genetic disorders
WO2022095972A1 (zh) 异喹啉类化合物在治疗肿瘤中的应用
US10722515B2 (en) Dual CLK/CDK1 inhibitors for cancer treatment
CN114796254A (zh) 多杀菌素衍生物作为精氨酸代琥珀酸合成酶激活剂及其应用
JP6343034B2 (ja) ナフチリジンジオン誘導体
US20220281803A1 (en) Molecular design of new antibiotics and antibiotic adjuvants against mcr strains
US10934326B2 (en) Peripheral modifications on pocket-redesigned vancomycin analogs synergistically improve antimicrobial potency and durability
US20230312597A1 (en) Novel compounds with antibacterial and anti viral activities
US20110263574A1 (en) Pirenzepine as otoprotective agent
US20190127313A1 (en) Antimicrobial agents
Buchkevych et al. Synthesis of New 6, 7 (N, O)-Heterocyclic 1, 4-Naphthoquinones
US20170100374A1 (en) Potentiator-corrector combinations useful in the treatment of cystic fibrosis
WO2013192301A1 (en) Imidazo bicyclic imminium compounds as antitumor agents
US20210393677A1 (en) Compounds for modulation and as functional replacement of alphaketoglutaric acid (2og)-dependent oxygenases
Malhotra et al. Benzylidene/2-aminobenzylidene hydrazides: Synthesis, characterization and in vitro antimicrobial evaluation
WO2025248025A1 (en) Inhibitors of the elongator complex
KR100780868B1 (ko) 항암효과를 나타내는 4급 아미노 글루코사민 화합물
US20200392126A1 (en) Isoxazolyl compounds as receptor modulating compounds and methods and uses thereof
Vilema Enriquez Epigenetic modification of the frataxin gene for the treatment of Friedreich’s ataxia
US20100022520A1 (en) Malonyl-coa acetyltransferase inhibitors against antibiotic resistant bactertia

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20211123